Using CRC in advancing therapies for head and neck cancer

Immunologist Anthony Cillo explores the range of immune responses to head and neck cancer in men to help in developing effective immunotherapies. He and collaborators used CRC’s advanced bioinformatics analysis resources in to examine immune cells from head and neck cancer patients to probe the question - why are immune responses markedly different in patients with cancer caused by the HPV virus versus cancers caused by carcinogens like smoking?

Read more at: "One cancer, two causes, many immune responses"